BGIM
BXRX

Brandywine Global Investment Management’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Brandywine Global Investment Management’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-156
Closed -$282K – 746
2021
Q1 		$282K Sell
156
-2
-1% -$4K ﹤0.01% 626
2020
Q4 		$223K Buy
158
+2
+1% +$4.09K ﹤0.01% 601
2020
Q3 		$606K Buy
156
+22
+16% +$99.5K 0.01% 514
2020
Q2 		$778K Buy
134
+2
+2% +$9.6K 0.01% 521
2020
Q1 		$459K Buy
132
+82
+164% +$774K 0.01% 557
2019
Q4 		$459K Buy
+50
New +$427K ﹤0.01% 597

Other funds holding BXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Brandywine Global Investment Management's BXRX Position: Q2 2021 in Review

Brandywine Global Investment Management sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q2 2021, closing a stake of 156 shares — an estimated $282K sold.

Brandywine Global Investment Management first reported a position in BXRX in Q4 2019 and held it in 6 quarters. The position peaked at $778K in Q2 2020. 31 funds tracked by Wall St. Rank hold BXRX as of Q2 2021.

  • Brandywine Global Investment Management reported no remaining Baudax Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Brandywine Global Investment Management sold 156 Baudax Bio, Inc. Common Stock shares in Q2 2021, an estimated $282K.
  • Brandywine Global Investment Management first reported a position in Baudax Bio, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Brandywine Global Investment Management's Baudax Bio, Inc. Common Stock position peaked at $778K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q2 2021.

Based on Brandywine Global Investment Management's 13F filing for Q2 2021, filed 13 Aug 2021.